DUBLIN--(BUSINESS WIRE)--The "IVD Infectious Diseases Market Size, Share & Trends Analysis Report By Test Location, By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics), And Segment Forecast, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
The global in-vitro diagnostics infectious diseases market size is likely to reach USD 31.45 billion by 2026, experiencing a CAGR of 6.7% during the forecast period. Increasing geriatric population and rising consumer awareness regarding the merits of IVD tests are expected to drive the IVD infectious diseases market.
Growing prevalence of target diseases, health awareness, and high demand for self-care medical devices are estimated to accentuate market growth over the forecast period. Moreover, introduction of technologically advanced products with improved sensitivity, speed, and user-friendliness are anticipated to increase the adoption of in-vitro diagnostics for infectious diseases in the next few years.
Key IVD techniques include immuno-chemistry assays, such as Enzyme-linked Immunosorbent Assay (ELISA) and Immuno-agglutination. These are widely used in clinical laboratories and diagnostic centers for detecting infectious microorganisms such as bacteria and virus in patient samples.
North America dominated the market, supported by presence of sophisticated healthcare infrastructure, government initiatives pertaining to research & development activities, and high awareness levels of patients and practitioners. The Asia Pacific IVD infectious diseases market is projected to witness the fastest growth over the forecast period.
Further key findings from the report suggest:
- Introduction of technologies such as qPCR and ELISA has enhanced usage rates of IVD products for infectious disease testing
- High unmet consumer needs, supported by rising disposable income and awareness levels in emerging markets, is a key growth stimulant
- Immunochemistry assays, such as ELISA and chemiluminescence immunoassays, are projected to be widely used over the forecast period
- Molecular diagnostics is poised to witness strong growth, driven by wide adoption and improved accuracy levels
- Key players in the market include Becton Dickinson; bioMerieux; Abbott Laboratories; Quidel Corporation; Alere Inc.; Orasure Technologies, Inc.; Hologic Inc.; Cepheid; Qiagen N.V.; Roche Diagnostics; Siemens Healthcare; and Bio-Rad Laboratories, Inc.
Topics Covered
Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.4. Information Analysis
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. IVD Infectious Diseases Market Variables, Trends & Scope
3.1. IVD Infectious Diseases Market Lineage outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Growing geriatric population base
3.4.1.2. Technological advancements
3.4.1.3. High demand for point of care facilities
3.4.1.4. Increasing prevalence of infectious diseases
3.4.1.5. External funding for R & D activities
3.4.2. Market Restraint Analysis
3.4.2.1. Ambiguous regulatory framework
3.4.2.2 High prices of IVD diagnostic tests3.5. IVD Infectious Diseases Market Analysis Tools
Chapter 4. IVD Infectious Diseases Market - Competitive Analysis
4.1. Recent Developments & Impact Analysis, by Key Market Participants
4.2. Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
4.3. Vendor Landscape
4.4. Public Companies
4.5. Private Companies
Chapter 5. IVD Infectious Diseases Market: Product Estimates & Trend Analysis
5.1. Definitions & Scope
5.3. IVD Infectious Diseases Market, by Product, 2014 to 2026
5.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
5.5. Product Markets, by Application, 2014-2026:
Chapter 6. IVD Market: Technology Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Technology Market Share Analysis, 2018 & 2026
6.3. IVD Infectious Diseases Market, by Technology, 2014 to 2026
6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
Chapter 7. IVD Market: Application Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Application Market Share Analysis, 2018 & 2026
7.3. IVD Infectious Diseases Market, by Application, 2014 to 2026
7.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
Chapter 8. IVD Market: Test Location Estimates & Trend Analysis
8.1. Definitions & Scope
8.2. Test location market share analysis, 2018 & 2026
8.3. IVD Infectious Diseases Market, by Test Location, 2014 to 2026
8.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
Chapter 9 IVD Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & Test Location
9.1 IVD Infectious Diseases Market: Regional Movement Analysis, 2018 & 2026
9.2 IVD Infectious Diseases Market: Leading Players, 2018:
9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
9.4 North America
9.5. Europe
9.6 Asia Pacific
9.7 Latin America
9.8 MEA
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Heat Map Analysis of Private Companies
10.3 Becton, Dickinson and Company
10.4 bioMrieux
10.5 Abbott Laboratories
10.6 Quidel Corporation
10.7 Alere Inc.
10.8 Orasure Technologies, Inc.
10.9 Hologic, Inc. (Gen Probe)
10.10 Cepheid
10.11 Qiagen N.V.
10.12 Roche Diagnostics
10.13 Siemens Healthcare
10.14 Bio-Rad Laboratories, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ln90np
